Clinical Trials in Lithuania — Country Dashboard | 238 EU Studies

Filter these 238 trials by condition, phase, sponsor and more.

Open in Search →

238 Registered trials

75 Recruiting

149 Completed trials

126 Sponsors active

76 Research sites

Phase III

Phase II

Phase III: 165 Phase II/III: 13 Phase II: 43 Phase I/II: 2 Phase IV: 5 Phase I: 3 Phase I (Other): 2 Phase I (FiH): 2 Other: 3

Oversight events in trials active here:

27 serious breaches 105 temporary halts 6 urgent safety measures 13 unexpected events 12 corrective measures across 44 trials

View oversight register →

Top conditions

Colitis ulcerative 8 Crohn's disease 5 Myelodysplastic syndrome 4 Non-small cell lung cancer 3 Rheumatoid arthritis 3 Multiple sclerosis 3 Chronic spontaneous urticaria 3 Chronic obstructive pulmonary disease 3 Relapsing multiple sclerosis 3 Malignant melanoma stage III 3 Chronic kidney disease 2 Pulmonary arterial hypertension 2

Top sponsors

Merck Sharp & Dohme LLC 14 AbbVie Deutschland GmbH & Co. KG 13 Novartis Pharma AG 11 Sanofi-Aventis Recherche & Developpement 11 Bayer AG 8 Amgen Inc. 7 Argenx 6 Boehringer Ingelheim International GmbH 5 Eli Lilly & Co. 5 Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting 5 Janssen - Cilag International 5 Novo Nordisk A/S 5

Cities with most trials

All trials — page 4

238 total

LSTA1 for subjects with newly diagnosed Glioblastoma Multiforme when added to standard of care (temozolomide) versus temozolomide Recruiting

2023-506813-23-00 Phase II Glioblastoma Multiforme Tartu University Hospital
Hidradenitis Suppurativa: Evaluation of Upadacitinib in Adult and Adolescent Subjects Recruiting

2023-503661-28-00 Phase III Hidradenitis Suppurativa Abbvie Deutschland GmbH & Co. KG
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting

2022-502851-79-00 Phase III Active Idiopathic Inflammatory Myopathy (IIM) Argenx
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Phase III Acute Myeloid Leukemia Prinses Maxima Centrum voor Kinderoncologie B.V.
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active SLE (POETYK SLE-1) Recruiting

2022-500699-76-00 Phase III Active Systemic Lupus Erythematosus (SLE) Bristol-Myers Squibb Services Unlimited Company
A study of MP0533 in patients with blood cancer. Recruiting

2023-505259-39-00 Phase I (FiH) Acute Myeloid Leukemia (AML) Molecular Partners AG
A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece… Recruiting

2023-504885-50-00 Phase III Treatment of children with chronic kidney disease and protei… Bayer AG
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Phase III Acute myocardial infarction (AMI) Viatris Innovation GmbH
Phase 1 Study of MK-1084 in KRAS mutant advanced solid tumors Recruiting

2022-501563-40-00 Phase I Solid tumor cancer and lung cancer Merck Sharp & Dohme LLC
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Phase III Juvenile psoriatic arthritis Amgen Inc.
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Phase IV Fluid overload/fluid accumulation Region Hovedstaden
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Phase II/III Acute Lymphoblastic Leukaemia Karolinska University Hospital
Extension study to assess effects of non-interrupted versus interrupted and long term treatment of two dose regimens on efficacy and safety … Recruiting

2023-508956-20-00 Phase III Hidradenitis suppurativa Novartis Pharma AG
Research study to evaluate the experimental drug ferumoxytol, to see how well it works for children with iron deficiency anemia (IDA) or who… Recruiting

2024-516264-28-00 Phase III Iron Deficiency Anemia (IDA) Amag Pharmaceuticals Inc.
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Phase III Advanced tumors Merck Sharp & Dohme LLC
A phase II trial of 177Lutetium-DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma LuDO-N Ended

2023-503684-42-00 Phase II Neuroblastoma Karolinska University Hospital
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended

2025-520488-42-00 Phase II Moderate-to-Severe Chronic Obstructive Pulmonary Disease (CO… Upstream Bio Inc.
A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Pharmacodynamics, Clinical Effects, and Safety between ABP 692… Ended

2024-512914-16-00 Phase III Relapsing-remitting Multiple Sclerosis Amgen Inc.
A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended

2024-516473-72-00 Phase III Multifocal Motor Neuropathy Argenx
A Study of Zolbetuximab Together with Pembrolizumab and Chemotherapy in Adults with Gastric Cancer Ended

2024-519773-19-00 Phase III Gastroesophageal Junction Adenocarcinoma Astellas Pharma Global Development Inc.
A Study to Compare Risankizumab to Vedolizumab in Adult Subjects With Moderate to Severe Ulcerative Colitis Ended

2024-518998-33-00 Phase III Ulcerative Colitis AbbVie Deutschland GmbH & Co. KG
Study to test new drug eftilagimod alfa (also known as efti) combined with standard marketed treatments (pembrolizumab and chemotherapy) in … Ended

2024-513621-23-00 Phase III Advanced/metastatic non-small cell lung cancer (NSCLC) Immutep
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Phase III Primary Sjögren’s Disease Argenx
A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended

2024-513210-36-00 Phase III Chronic Spontaneous Urticaria Celldex Therapeutics Inc.

Showing 73–96 of 238 trials

← All countries